Regina M. Black

Statistics

Publications

Citations

566

H-Index

Active since

1981

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Agilent Technologies (United States)

Regina M. Black is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1981–2021

Publications

Benzoyl 2-methyl indoles as selective PPARγ modulators

John J. Acton, Regina M. Black, A. Brian Jones et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 131 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9

Synthesis, stability, and biological evaluation of water-soluble prodrugs of a new echinocandin lipopeptide. Discovery of a potential clinical agent for the treatment of systemic candidiasis and Pneumocystis carinii pneumonia (PCP)

James M. Balkovec, Regina M. Black, Milton L. Hammond et al. · Journal of Medicinal Chemistry · 1992 · 71 citations

Medicine, Medicinal Chemistry, Pharmacology +10

Design and Synthesis of C<sub>2</sub>-Symmetric N-Heterocyclic Carbene Precursors and Metal Carbenoids

Abigail Albright, D. Eddings, Regina M. Black et al. · The Journal of Organic Chemistry · 2011 · 68 citations

Natural Sciences, Chemistry, Drug Discovery +15

Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species.

Dennis M. Schmatz, George K. Abruzzo, Maryann Powles et al. · The Journal of Antibiotics · 1992 · 64 citations · Full text

Life Sciences, Medicinal Chemistry, Microbiology +10

Selective PPARγ modulators with improved pharmacological profiles

Kun Liu, Regina M. Black, John J. Acton et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 62 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

1–5 of 14